Naci, Huseyin and Cylus, Jonathan (2012) Why a stricter regulation of drugs could foster (not deter) pharmaceutical innovation. British Politics and Policy at LSE (21 Sep 2012) Blog Entry.
Download (159Kb) | Preview
Huseyin Naci and Jonathan Cylus provide arguments for how to improve the regulation concerning pharmaceutical drugs. Since drugs are not assessed relative to alternatives on the market, they claim it becomes more difficult to accurately evaluate a drug’s successes and harms. Increased innovation and a more streamlined delivery of information are some of the benefits they attribute to more rigorous drug regulations.
|Item Type:||Website (Blog Entry)|
|Additional Information:||© 2012 The Authors|
|Library of Congress subject classification:||R Medicine > RA Public aspects of medicine|
|Sets:||Collections > British Politics and Policy at LSE
Research centres and groups > LSE Health and Social Care
Research centres and groups > ALPHA (Ageing, Lifecourse and Population Health Analysis)
|Date Deposited:||13 Feb 2013 11:47|
Actions (login required)
|Record administration - authorised staff only|